Top 10 Most Expensive Medical Treatments and Their Costs

Top 10 Most Expensive Medical Treatments and Their Costs

Healthcare costs are rising. Some medical treatments cost a fortune. Expensive treatments involve advanced technology. Specialized doctors perform these procedures. Hospital stays can be long and costly. Some therapies require rare medicines. Complex procedures add to the expense. Here is a list of the top 10 most expensive medical treatments.

1. Zolgensma – Rs 174 Crore

  • Zolgensma is the most expensive drug.
  • It treats spinal muscular atrophy (SMA).
  • SMA is a rare genetic disorder.
  • The disease affects muscle control.
  • A single dose can prevent further damage.
  • Infants with SMA benefit from early treatment.
  • The treatment improves muscle movement.
  • It is a one-time gene therapy.
TreatmentCostUsed For
ZolgensmaRs 174 CroreSpinal muscular atrophy (SMA)

2. Luxturna – Rs 70 Crore

  • Luxturna is a gene therapy.
  • It treats inherited vision loss.
  • Patients suffer from a rare eye disease.
  • The disease causes blindness over time.
  • The treatment corrects the defective gene.
  • A one-time therapy helps restore vision.
  • The high cost is due to its effectiveness.
TreatmentCostUsed For
LuxturnaRs 70 CroreInherited vision loss

3. Kymriah – Rs 39 Crore

  • Kymriah is a CAR T-cell therapy.
  • It treats leukemia in children and young adults.
  • The treatment modifies immune cells.
  • These modified cells fight cancer.
  • Kymriah is a one-time treatment.
  • It is different from chemotherapy.
  • The process is complex and costly.
TreatmentCostUsed For
KymriahRs 39 CroreLeukemia treatment

4. Skysona – Rs 249 Crore

  • Skysona is a gene therapy.
  • It treats cerebral adrenoleukodystrophy (CALD).
  • CALD is a rare brain disease.
  • The disorder leads to neurological decline.
  • Skysona corrects faulty genes.
  • A single dose helps prevent progression.
  • The treatment is extremely costly.
TreatmentCostUsed For
SkysonaRs 249 CroreCerebral adrenoleukodystrophy

5. Hemgenix – Rs 290 Crore

  • Hemgenix is a gene therapy.
  • It treats hemophilia B.
  • Hemophilia B is a rare bleeding disorder.
  • Patients lack a crucial clotting protein.
  • Hemgenix helps the body produce the protein.
  • It reduces the need for lifelong treatments.
  • Regular injections are no longer required.
TreatmentCostUsed For
HemgenixRs 290 CroreHemophilia B

6. Zokinvy – Rs 85 Crore

  • Zokinvy treats progeria syndrome.
  • Progeria causes rapid aging in children.
  • The disorder is extremely rare.
  • The drug slows down aging symptoms.
  • It helps increase the lifespan of children.
  • The treatment is expensive due to research costs.
TreatmentCostUsed For
ZokinvyRs 85 CroreProgeria Syndrome

7. Carvykti – Rs 38 Crore

  • Carvykti is a CAR T-cell therapy.
  • It treats multiple myeloma.
  • This is a type of blood cancer.
  • The therapy reprograms immune cells.
  • It improves survival rates.
  • The high cost is due to effectiveness.
  • The treatment is a one-time procedure.
TreatmentCostUsed For
CarvyktiRs 38 CroreMultiple myeloma

8. Strimvelis – Rs 55 Crore

  • Strimvelis is a gene therapy.
  • It treats ADA-SCID (Bubble Boy Disease).
  • Children with this disorder have weak immunity.
  • Infections are a major risk for them.
  • Strimvelis helps strengthen the immune system.
  • The therapy is highly expensive.
TreatmentCostUsed For
StrimvelisRs 55 CroreADA-SCID (Bubble Boy Disease)

9. Folotyn – Rs 26 Crore

  • Folotyn is a chemotherapy drug.
  • It treats peripheral T-cell lymphoma (PTCL).
  • PTCL is a rare blood cancer.
  • The drug stops cancer cell growth.
  • Research and development add to the cost.
TreatmentCostUsed For
FolotynRs 26 CrorePeripheral T-cell lymphoma

10. Actimmune – Rs 16 Crore

  • Actimmune treats rare immune disorders.
  • It helps with chronic granulomatous disease (CGD).
  • It also treats osteopetrosis.
  • CGD weakens the immune system.
  • Osteopetrosis makes bones overly dense.
  • Actimmune improves immune response.
TreatmentCostUsed For
ActimmuneRs 16 CroreChronic granulomatous disease

Key Takeaways

  • Medical advancements save lives.
  • Treatments for rare diseases are costly.
  • High prices make them unaffordable for many.
  • Gene therapies offer hope for rare disorders.
  • Governments must work to make treatments affordable.
  • Insurance and financial aid help some patients.
  • A global effort is needed to reduce medical costs.

Leave a Comment